These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8028278)

  • 1. Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.
    Bacher JD; Balis FM; McCully CL; Godwin KS
    Lab Anim Sci; 1994 Apr; 44(2):148-52. PubMed ID: 8028278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.
    Balis FM; Blaney SM; McCully CL; Bacher JD; Murphy RF; Poplack DG
    Cancer Chemother Pharmacol; 2000; 45(3):259-64. PubMed ID: 10663645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid.
    McCully CL; Balis FM; Bacher J; Phillips J; Poplack DG
    Lab Anim Sci; 1990 Sep; 40(5):520-5. PubMed ID: 2170754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
    Shapiro WR; Young DF; Mehta BM
    N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primate model for study of methotrexate pharmacokinetics in the central nervous system.
    Poplack DG; Bleyer WA; Wood JH; Kostolich M; Savitch JL; Ommaya AK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1982-5. PubMed ID: 405092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolites in rhesus monkeys.
    Johnston MV; Silverstein FS; Greenberg H; Knutsen CA; Chandler W; Phillips T; Ensminger WD
    Cancer Treat Rep; 1986 Oct; 70(10):1205-9. PubMed ID: 2428491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active transport of methotrexate from cerebrospinal fluid in humans.
    Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL
    Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W; Widemann B; McCully C; Adamson PC; Balis FM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of elimination of methotrexate from the cerebrospinal fluid space of monkeys after ventriculolumbar perfusion.
    Merker PC; Mehta BM; Cantor ML; Hutchison DJ
    Cancer Treat Rep; 1977 Jul; 61(4):603-11. PubMed ID: 406994
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid formation in ventricles and spinal subarachnoid space of the rhesus monkey.
    Lux WE; Fenstermacher JD
    J Neurosurg; 1975 Jun; 42(6):674-8. PubMed ID: 1095693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure.
    Wood JH; Poplack DG; Bleyer WA; Ommaya AK
    Science; 1977 Feb; 195(4277):499-501. PubMed ID: 402027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
    Fujimoto T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implanted system for intraventricular drug infusion in central nervous system tumors.
    Dakhil S; Ensminger W; Kindt G; Niederhuber J; Chandler W; Greenberg H; Wheeler R
    Cancer Treat Rep; 1981; 65(5-6):401-11. PubMed ID: 6263475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
    Kimelberg HK; Biddlecome SM; Bourke RS
    Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
    Blasberg RG; Patlak CS; Shapiro WR
    Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
    [No Abstract]   [Full Text] [Related]  

  • 17. Lumbar catheterization of the subarachnoid space with a 32-gauge polyurethane catheter in the rat.
    Pogatzki EM; Zahn PK; Brennan TJ
    Eur J Pain; 2000; 4(1):111-3. PubMed ID: 10833561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological effects of methotrexate perfused through the cerebrospinal fluid system of the rhesus monkey.
    Shepard RF; Merker PC; Walker MD; Gilles FH
    Cancer Res; 1976 Oct; 36(10):3771-8. PubMed ID: 821606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
    Bleyer WA; Dedrick RL
    Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys.
    Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG
    Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.